The Asia-Pacific corn/maize seed treatment market had an estimated value of USD 101.0 million in 2016 and is estimated to grow further witnessing a CAGR of 12.1% during the forecast period (2018-2023).
Corn constitutes a major portion of the seed treatment market in the Asia-Pacific region. The market share is close to 25% on a global level and the region is expected to stay dominant during the forecast period. China is the largest consumer of seed treatment chemicals for maize, followed by India, with a market share of approximately 6% of the market.
Maize cultivation in Asian countries, like India and China, is more prone to diseases, like post flowering stalk rot (PFSR). It is a complex disease that involves more than one pathogen, it is caused by fusarium verticillioides, macrophomina phaseolina, and harpophora maydis. The disease causes yield loss due to premature plant death or by reduced kernel filling and lodging. The incidence of such diseases can be reduced by usage of treated seed in the region.
China is the largest market for corn/maize seed treatment in the Asia-Pacific region, it accounts for nearly 90% of the market share in the region. The Chinese government lays a great emphasis on seed treatment, as the process plays a significant role in improving crop performance by enhancing yields even under unfavorable conditions. The government has launched several initiatives, such as training the farmers with seed treatment technology, farming subsidies, and encouraging farmers to sow treated seeds.
Major Players: Advanced Biological Marketing Inc., Bayer CropScience AG, DowDuPont, and Syngenta, among others.
Looking to Customize Report?